Canada markets closed

Centogene N.V. (CNTG)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.2100-0.0500 (-3.97%)
At close: 04:00PM EDT
1.2400 +0.03 (+2.48%)
After hours: 04:27PM EDT
Full screen
Loading interactive chart...
  • GlobeNewswire

    CENTOGENE Reaches 12,500 Patient Milestone in World’s Largest Observational Study on Parkinson’s Disease Genetics

    Working together with Denali Therapeutics to accelerate data-driven precision medicine for the PD community Rostock International Parkinson's Disease (ROPAD) Study aims to characterize the genetics of PD to establish a better understanding of the disease progression, diagnosis, and treatmentWorldwide 120 study sites marks this as the largest observational study for genetics in PD CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), th

  • GlobeNewswire

    CENTOGENE to Present at Upcoming Investor & Partnering Conferences in September

    CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the commercial-stage essential biodata life science partner for rare and neurodegenerative diseases, today announced its investment and partnering conference schedule for September 2022. Company management will present at the H.C. Wainwright 24th Annual Global Investment Conference in New York and the 9th Annual HealthTech Investment Forum (HTIF) as part of Sachs Autumn Life Scienc

  • GlobeNewswire

    CENTOGENE Reports First Quarter 2022 Financial Results

    On Track for FY 2022 Guidance Q1 2022 revenue rises 3% to €10.3 million Completed phase out of COVID-19 Business segment in Q1 2022Positioning Pharma and Diagnostics for post-COVID recovery and growth in 2022 and beyondReaffirms FY 2022 guidance of 15-20% revenue growth CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 15, 2022 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the commercial-stage essential biodata life science partner for rare and neurodegenerative diseases, today announc